We aim to grow our Healthcare Business to ¥90 billion in fiscal year 2014 and ¥100 billion in fiscal year 2016. At this time, our cassette-type DR systems are being installed at an increasing rate, especially in large hospitals. This is because of their small footprint and their high-definition superiority. Going forward, we plan to target the replacement market and expand installations in smaller clinics with lower-priced systems. We aim to develop new diagnostic fields with video and Talbot technology. Outside our own channels, we will try to expand OEM and the B2B field. Our target is to grow sales by ¥14 billion between fiscal years 2013 and 2016. Ultrasound diagnostic systems are a category begun in fiscal year 2013. We aim to establish the top of the market with high-picture-quality probes. We expect sales to grow in areas that can really take advantage of our products, such as the orthopedic, mammary gland, and internal medicine market. We project sales will rise by ¥7 billion between fiscal years 2013 and 2016. Sales of maintenance and service incidental to such diagnostic imaging will become a new revenue source. Also, instead of trying to imitate technologies like conventional electronic medical charts, we will propose regional partnership solutions that anticipate cloud-based service extending even to at-home medical care. Through these, we will work to expand sales by ¥8 billion between fiscal years 2013 and 2016.